Cargando…

A prospective study comparing patient-reported outcomes in Crohn’s disease

Patient reported outcomes are important in Crohn’s disease. In this prospective cohort, we investigated the performance of the Bristol Stool Form Scale (BSFS) and a visual analog scale (VAS) for abdominal pain as outcome measures in Crohn’s disease. METHODS: Patients with active Crohn’s disease star...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoekman, Daniël R., Löwenberg, Mark, van den Brink, Gijs R., Ponsioen, Cyriel Y., Benninga, Marc A., D’Haens, Geert R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2020
Materias:	Original Articles: Gastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903328/ https://www.ncbi.nlm.nih.gov/pubmed/31651651 http://dx.doi.org/10.1097/MEG.0000000000001568

Ejemplares similares

Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease
por: de Bruyn, Jessica R., et al.
Publicado: (2018)

Case report of cheilitis granulomatosa and joint complaints as presentation of Crohn’s disease
por: Hoekman, Daniël R., et al.
Publicado: (2016)

Characterization of Mucosal Lesions in Crohn's Disease Scored With Capsule Endoscopy: A Systematic Review
por: Marquès Camí, Miquel, et al.
Publicado: (2021)

Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

Assessing Disease Activity in Pediatric Crohn’s Disease Using Ultrasound: The Pediatric Crohn Disease Intestinal Ultrasound Score
por: van Wassenaer, Elsa A., et al.
Publicado: (2023)

Next-Generation Therapeutics for IBD
por: Löwenberg, Mark, et al.
Publicado: (2015)

Hemolytic anemia after switching from infliximab originator to biosimilar CT‐P13 in a patient with inflammatory bowel disease: A case report
por: Strik, Anne S., et al.
Publicado: (2019)

Impaired Quality of Working Life in Inflammatory Bowel Disease Patients
por: van Gennep, Sara, et al.
Publicado: (2020)

Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study
por: Hanzel, Jurij, et al.
Publicado: (2021)

Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn’s disease
por: Lansdorp, Corine A., et al.
Publicado: (2020)

Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study
por: Hanzel, Jurij, et al.
Publicado: (2021)

Macroscopic to Microscopic – A Case of Crohn’s Disease Progressing to Collagenous Colitis
por: Hussain, Murtaza Shabbir, et al.
Publicado: (2021)

Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index
por: Bots, Steven, et al.
Publicado: (2021)

Hepatocellular Carcinoma in a Patient With Crohn’s Disease
por: Hokama, Akira, et al.
Publicado: (2021)

The Use of Vedolizumab in Patients with Concomitant Cirrhosis and Crohn’s Disease
por: Kapila, Nikhil, et al.
Publicado: (2018)

An Unusual Presentation of Crohn’s Disease and Primary Sclerosing Cholangitis
por: Ekanayake, Lakmal S, et al.
Publicado: (2022)

Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis
por: Berends, Sophie E., et al.
Publicado: (2018)

High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study
por: van Gennep, Sara, et al.
Publicado: (2020)

Acute Intestinal Invagination: An Exceptional Method of Revealing Crohn’s Disease
por: Jabi, Rachid, et al.
Publicado: (2021)

Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT‐TOPIC trial after 1‐year follow‐up
por: Lansdorp, Corine A., et al.
Publicado: (2022)

Wernicke’s Encephalopathy in a Patient With Crohn’s Disease: A Case Report
por: Adamou, Fatima, et al.
Publicado: (2023)

A Challenging Case of Metastatic Crohn's Disease Without Gastrointestinal Manifestations
por: Pereira, Ana S, et al.
Publicado: (2023)

Meckel’s Diverticulum Charading as Crohn’s Disease: A Single-Institution Case Series
por: Eng, Nina L, et al.
Publicado: (2023)

Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial
por: Hoekman, Daniël R, et al.
Publicado: (2020)

Helicobacter pylori is Associated with Less Fistulizing, Stricturing, and Active Colitis in Crohn’s Disease Patients
por: Fialho, Andre, et al.
Publicado: (2019)

Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy alone for Crohn's perianal fistulas (PISA-II): long-term outcomes of an international, multicentre patient preference, randomised controlled trial
por: Meima - van Praag, Elise M., et al.
Publicado: (2023)

Population pharmacokinetics of subcutaneous infliximab CT‐P13 in Crohn’s disease and ulcerative colitis
por: Hanzel, Jurij, et al.
Publicado: (2021)

Identifying Visceral Kaposi Sarcoma (KS): A Responsibility to Avoid Anchoring on the Diagnosis of a Crohn’s Flare
por: Seltzer, Emily S, et al.
Publicado: (2023)

Atypical Clinical Presentation of Crohn’s Disease as Diffuse Abdominal Lymphadenopathy and Venous Thrombosis: A Difficult to Diagnose Case
por: Raza, Ahmad, et al.
Publicado: (2019)

Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn’s Disease
por: Kim, Sun, et al.
Publicado: (2021)

Prevalence of suspected child abuse in children with constipation: a case–control study
por: Vriesman, Mana H, et al.
Publicado: (2022)

Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm
por: Bots, S, et al.
Publicado: (2021)

Clinical and Histologic Remission in an Adult Crohn’s Disease Patient Following the Specific Carbohydrate Diet and Its Impact on Healthcare Costs
por: Arjomand, Ali, et al.
Publicado: (2022)

Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn’s disease or ulcerative colitis
por: Gheorghe, Cristian, et al.
Publicado: (2019)

Polyethylene Glycol 3350 With Electrolytes Versus Polyethylene Glycol 4000 for Constipation: A Randomized, Controlled Trial
por: Bekkali, Noor L.H., et al.
Publicado: (2018)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
por: Paulides, Emma, et al.
Publicado: (2022)

Comparative Study of Perioperative Outcomes Between Modified Blumgart Duct to Mucosa and Dunking Pancreaticojejunostomy
por: Adhikari, Krishna M, et al.
Publicado: (2023)

Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting
por: Volkers, Adriaan, et al.
Publicado: (2023)

A Prospective Study on the Clinical Significance of Infections in a Hospital Setting Among the Cirrhotic Patients and Their Outcomes
por: Patnaik, Swarup K, et al.
Publicado: (2023)

Long-term effectiveness and safety of ustekinumab in Crohn’s disease: a prospective cohort study
por: Thomas, Pepijn W.A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kundlgmm2qusir0tokeu56kg81